These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

661 related articles for article (PubMed ID: 17827019)

  • 1. Phenylethyl-substituted pyrimido[2,1-f]purinediones and related compounds: structure-activity relationships as adenosine A(1) and A(2A) receptor ligands.
    Drabczyńska A; Müller CE; Schiedel A; Schumacher B; Karolak-Wojciechowska J; Fruziński A; Zobnina W; Yuzlenko O; Kieć-Kononowicz K
    Bioorg Med Chem; 2007 Nov; 15(22):6956-74. PubMed ID: 17827019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological activity of tricyclic aryloimidazo-, pyrimido-, and diazepinopurinediones.
    Drabczyńska A; Müller CE; Lacher SK; Schumacher B; Karolak-Wojciechowska J; Nasal A; Kawczak P; Yuzlenko O; Pekala E; Kieć-Kononowicz K
    Bioorg Med Chem; 2006 Nov; 14(21):7258-81. PubMed ID: 16844379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological activity of tricyclic cycloalkylimidazo-, pyrimido- and diazepinopurinediones.
    Drabczyńska A; Yuzlenko O; Köse M; Paskaleva M; Schiedel AC; Karolak-Wojciechowska J; Handzlik J; Karcz T; Kuder K; Müller CE; Kieć-Kononowicz K
    Eur J Med Chem; 2011 Sep; 46(9):3590-607. PubMed ID: 21664729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tricyclic oxazolo[2,3-f]purinediones: potency as adenosine receptor ligands and anticonvulsants.
    Drabczyńska A; Müller CE; Schumacher B; Hinz S; Karolak-Wojciechowska J; Michalak B; Pekala E; Kieć-Kononowicz K
    Bioorg Med Chem; 2004 Sep; 12(18):4895-908. PubMed ID: 15336269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N9-benzyl-substituted 1,3-dimethyl- and 1,3-dipropyl-pyrimido[2,1-f]purinediones: synthesis and structure-activity relationships at adenosine A1 and A2A receptors.
    Drabczyńska A; Müller CE; Karolak-Wojciechowska J; Schumacher B; Schiedel A; Yuzlenko O; Kieć-Kononowicz K
    Bioorg Med Chem; 2007 Jul; 15(14):5003-17. PubMed ID: 17499511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chiral pyrrolo[2,3-d]pyrimidine and pyrimido[4,5-b]indole derivatives: structure-activity relationships of potent, highly stereoselective A1-adenosine receptor antagonists.
    Müller CE; Geis U; Grahner B; Lanzner W; Eger K
    J Med Chem; 1996 Jun; 39(13):2482-91. PubMed ID: 8691445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5'-Carbamoyl derivatives of 2'-C-methyl-purine nucleosides as selective A1 adenosine receptor agonists: affinity, efficacy, and selectivity for A1 receptor from different species.
    Cappellacci L; Franchetti P; Vita P; Petrelli R; Lavecchia A; Costa B; Spinetti F; Martini C; Klotz KN; Grifantini M
    Bioorg Med Chem; 2008 Jan; 16(1):336-53. PubMed ID: 17933541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological activity of new potential agonists for the human adenosine A2A receptor.
    Bosch MP; Campos F; Niubó I; Rosell G; Díaz JL; Brea J; Loza MI; Guerrero A
    J Med Chem; 2004 Jul; 47(16):4041-53. PubMed ID: 15267242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists.
    Baraldi PG; Tabrizi MA; Preti D; Bovero A; Romagnoli R; Fruttarolo F; Zaid NA; Moorman AR; Varani K; Gessi S; Merighi S; Borea PA
    J Med Chem; 2004 Mar; 47(6):1434-47. PubMed ID: 14998332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, biological and modeling studies of 1,3-di-n-propyl-2,4-dioxo-6-methyl-8-(substituted) 1,2,3,4-tetrahydro [1,2,4]-triazolo [3,4-f]-purines as adenosine receptor antagonists.
    Pastorin G; Bolcato C; Cacciari B; Kachler S; Klotz KN; Montopoli C; Moro S; Spalluto G
    Farmaco; 2005 Aug; 60(8):643-51. PubMed ID: 15961085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1,3-dialkyl-8-N-substituted benzyloxycarbonylamino-9-deazaxanthines as potent adenosine receptor ligands: Design, synthesis, structure-affinity and structure-selectivity relationships.
    Fernández F; Caamaño O; Isabel Nieto M; López C; García-Mera X; Stefanachi A; Nicolotti O; Isabel Loza M; Brea J; Esteve C; Segarra V; Vidal B; Carotti A
    Bioorg Med Chem; 2009 May; 17(10):3618-29. PubMed ID: 19398343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and structure-activity relationships of 1-,3-,8-, and 9-substituted-9-deazaxanthines at the human A2B adenosine receptor.
    Carotti A; Cadavid MI; Centeno NB; Esteve C; Loza MI; Martinez A; Nieto R; Raviña E; Sanz F; Segarra V; Sotelo E; Stefanachi A; Vidal B
    J Med Chem; 2006 Jan; 49(1):282-99. PubMed ID: 16392813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, biological assays and QSAR studies of N-(9-benzyl-2-phenyl-8-azapurin-6-yl)-amides as ligands for A1 adenosine receptors.
    Giorgi I; Leonardi M; Pietra D; Biagi G; Borghini A; Massarelli I; Ciampi O; Bianucci AM
    Bioorg Med Chem; 2009 Mar; 17(5):1817-30. PubMed ID: 19230680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Derivatives of 4-amino-6-hydroxy-2-mercaptopyrimidine as novel, potent, and selective A3 adenosine receptor antagonists.
    Cosimelli B; Greco G; Ehlardo M; Novellino E; Da Settimo F; Taliani S; La Motta C; Bellandi M; Tuccinardi T; Martinelli A; Ciampi O; Trincavelli ML; Martini C
    J Med Chem; 2008 Mar; 51(6):1764-70. PubMed ID: 18269230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, biological activity and molecular modelling studies of tricyclic alkylimidazo-, pyrimido- and diazepinopurinediones.
    Drabczyńska A; Karcz T; Szymańska E; Köse M; Müller CE; Paskaleva M; Karolak-Wojciechowska J; Handzlik J; Yuzlenko O; Kieć-Kononowicz K
    Purinergic Signal; 2013 Sep; 9(3):395-414. PubMed ID: 23543220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New arylpiperazine 5-HT(1A) receptor ligands containing the pyrimido[2,1-f]purine fragment: synthesis, in vitro, and in vivo pharmacological evaluation.
    Jurczyk S; Kołaczkowski M; Maryniak E; Zajdel P; Pawłowski M; Tatarczyńska E; Kłodzińska A; Chojnacka-Wójcik E; Bojarski AJ; Charakchieva-Minol S; Duszyńska B; Nowak G; Maciag D
    J Med Chem; 2004 May; 47(10):2659-66. PubMed ID: 15115407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and biological evaluation of C9- and C2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as new A2A and A3 adenosine receptors antagonists.
    Baraldi PG; Fruttarolo F; Tabrizi MA; Preti D; Romagnoli R; El-Kashef H; Moorman A; Varani K; Gessi S; Merighi S; Borea PA
    J Med Chem; 2003 Mar; 46(7):1229-41. PubMed ID: 12646033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1,3-Dialkyl-substituted tetrahydropyrimido[1,2-f]purine-2,4-diones as multiple target drugs for the potential treatment of neurodegenerative diseases.
    Koch P; Akkari R; Brunschweiger A; Borrmann T; Schlenk M; Küppers P; Köse M; Radjainia H; Hockemeyer J; Drabczyńska A; Kieć-Kononowicz K; Müller CE
    Bioorg Med Chem; 2013 Dec; 21(23):7435-52. PubMed ID: 24139167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of a series of 8-(substituted-phenyl)xanthines and a study on the effects of substitution pattern of phenyl substituents on affinity for adenosine A(1) and A(2A) receptors.
    Bansal R; Kumar G; Gandhi D; Young LC; Harvey AL
    Eur J Med Chem; 2009 May; 44(5):2122-7. PubMed ID: 19036477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of some quinoline-2(1H)-one and 1, 2, 4 - triazolo [ 4 , 3 -a ] quinoline derivatives as potent anticonvulsants.
    Guan LP; Jin QH; Tian GR; Chai KY; Quan ZS
    J Pharm Pharm Sci; 2007; 10(3):254-62. PubMed ID: 17727789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.